Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T
reg
cells
Nature
.
2024 Jun;630(8016):E9.
doi: 10.1038/s41586-024-07562-2.
Authors
Xiangnan Guan
1
,
Ruozhen Hu
1
,
Yoonha Choi
1
,
Shyam Srivats
1
,
Barzin Y Nabet
1
,
John Silva
1
,
Lisa McGinnis
1
,
Robert Hendricks
1
,
Katherine Nutsch
1
,
Karl L Banta
1
,
Ellen Duong
1
,
Alexis Dunkle
1
,
Patrick S Chang
1
,
Chia-Jung Han
1
,
Stephanie Mittman
1
,
Nandini Molden
1
,
Pallavi Daggumati
1
,
Wendy Connolly
1
,
Melissa Johnson
2
,
Delvys Rodriguez Abreu
3
,
Byoung Chul Cho
4
,
Antoine Italiano
5
6
,
Ignacio Gil-Bazo
7
,
Enriqueta Felip
8
,
Ira Mellman
1
,
Sanjeev Mariathasan
1
,
David S Shames
1
,
Raymond Meng
1
,
Eugene Y Chiang
1
,
Robert J Johnston
9
,
Namrata S Patil
10
Affiliations
1
Genentech Inc., South San Francisco, CA, USA.
2
Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
3
Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.
4
Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea.
5
Institut Bergonie CLCC Bordeaux, Bordeaux, France.
6
Faculty of Medicine, University of Bordeaux, Bordeaux, France.
7
Clínica Universidad de Navarra, CIMA Universidad de Navarra Pamplona, Pamplona, Spain.
8
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
9
Genentech Inc., South San Francisco, CA, USA. johnston.robert@gene.com.
10
Genentech Inc., South San Francisco, CA, USA. patil.namrata@gene.com.
PMID:
38816613
PMCID:
PMC11168920
DOI:
10.1038/s41586-024-07562-2
No abstract available
Publication types
Published Erratum